VOLITIONRX LTD 8-K

What Happened
VolitionRx Ltd (VNRX) filed an 8-K (Item 5.02) reporting that director Mickie Henshall notified the board on May 12, 2026 that she will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders. Ms. Henshall has served on the board since August 2022, and her decision reportedly does not involve any disagreement with the company on its operations, policies or practices. The board will reduce its size from eight directors to seven effective immediately prior to the 2026 Annual Meeting.

Key Details

• Notification date: May 12, 2026; 8-K filed May 15, 2026.
• Director leaving: Mickie Henshall, board member since August 2022.
• Reason: Decision not to stand for re-election; company states no disagreement with operations, policies or practices.
• Board change: Size reduced from 8 to 7 directors effective immediately before the 2026 Annual Meeting.

Why It Matters
This is a governance update that changes the composition and size of VolitionRx’s board. It is a factual item for investors to note; there are no stated disagreements or allegations tied to the departure. Investors should watch future filings (e.g., proxy statements) for any director nominations, committee reassignments, or additional governance disclosures ahead of the 2026 Annual Meeting.